Canna~Fangled Abstracts Cannabinoids and endocannabinoids as therapeutics for nervous system disorders: preclinical models and clinical studies Review Neural Regen Res. 2024 Apr;19(4):788-799. doi: 10.4103/1673-5374.382220. R Scott Duncan 1, Sean M Riordan 1, Matthew C Gernon 1, Peter…Freedom WaresApril 19, 2023
Canna~Fangled Abstracts The impact of phyto- and endo-cannabinoids on central nervous system diseases:A review Journal List J Tradit Complement Med v.13(1); 2023 Jan PMC9845650 J Tradit Complement Med. 2023 Jan;…Freedom WaresJanuary 12, 2023
Canna~Fangled Abstracts Between Science and Big Business: Tapping Mary Jane’s Uncharted Potential Journal List > ACS Cent Sci > v.8(2); 2022 Feb 23 > PMC8875429 ACS Cent…Freedom WaresFebruary 23, 2022
Canna~Fangled Abstracts Polypharmacological Approaches for CNS Diseases: Focus on Endocannabinoid Degradation Inhibition Review Cells. 2022 Jan 29;11(3):471. doi: 10.3390/cells11030471. Alessandro Papa 1, Silvia Pasquini 2, Chiara Contri 2, Sandra Gemma 1, Giuseppe Campiani 1, Stefania Butini 1, Katia Varani 2, Fabrizio…Freedom WaresJanuary 29, 2022
Canna~Fangled Abstracts Cannabidiol enhances the passage of lipid nanocapsules across the blood-brain barrier both in vitro and in vivo. Mol Pharm. 2019 Mar 13. doi: 10.1021/acs.molpharmaceut.8b01344. Aparicio-Blanco J, Romero IA, Male DK, Slowing K,…Freedom WaresMarch 3, 2019